Despite therapeutic advantages, double-donor (DD) HSCTs present technical problems for molecular chimerism (CHM) monitoring. These DD chimeras contain three matched DNAs, so that the genomes of donor(s) and recipient often share the same alleles. In the STR assay, shared recipient/donor alleles are common and have identical physico-chemical properties. As a consequence of the latter, they co-migrate in the same band ('shared peak'), which prevents measuring each allele separately. Without individual allelic measurements, the direct calculation of the chimeric recipient/donor DNA ratio is precluded. This is the first study to document and systematically examine these problems. Its goal was to provide a validated framework for accurate, routine monitoring based on a stepwise analytic paradigm for approximating percent CHM (%CHM) from shared STR-alleles. Analysis of STR-DNA from DD loci showed that at least four of six alleles were typically shared. Despite such extensive allelic sharing, we show how simple arithmetic procedures can be applied for standardized calculation of %CHM based on peak measurements. Criteria for selecting loci suitable for such analysis are provided. Validation of the computational results required analyzing 18 'informative' loci with pre-established reference values for %CHM. In all cases, the results for %CHM, calculated from peak measurements, were ± 5% of the reference value. The conclusions of the study are as follows: (1) Multi-donor chimeras, with shared alleles, can be accurately and simply analyzed within the usual limits of STR measurement error; (2) by examining these various facets of DD CHM analysis, this novel study has provided a basis for standardized, routine quantitative monitoring using the STR/VNTR assay.
Introduction
Multi-donor chimeric states are increasingly being encountered in laboratories charged with monitoring allogeneic hematopoietic SCT (HSCTs). This trend partially reflects more frequent use of double-donor (DD) HSCTs, a promising strategy to expedite engraftment and improve outcome of transplantation. It is most commonly exemplified in DD cord blood transplants, and combined cord blood and haploidentical transplants. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] However, similar complex chimeric states can occur after sequential singledonor HSCTs and in the setting of feto-maternal chimerism (CHM) followed by HSCT. [14] [15] [16] [17] [18] [19] Despite their advantages, such clinical achievements also engender new challenges for post-transplantation monitoring, particularly in regard to the molecular evaluation of chimeric status. An analysis of hematopoietic CHM is useful for assessing engraftment because it provides an estimate of the ratio of donor-to-recipient DNA-or cellsin the patient. The results, therefore, are quantitative and are reported as 'percent CHM' (%CHM).
Quantitative evaluation of CHM most often uses a polymorphic system of DNA biomarkers, such as STRs (VNTRs). [20] [21] [22] [23] [24] STRs are short sequences of nucleotides that are randomly and variably repeated throughout the genome. 25 Using this quantitative approach, it is possible to assess the full range of CHM values, from 0 to 100%. With that capability, it is possible to compare results between samples, and thereby detect small, incremental changes in an individual patient's chimeric level and engraftment status.
The assay involves PCR followed by electrophoresis of the STR-DNA. During electrophoresis, the migrating bands (peaks) of STR-DNA are measured, which enables the chimeric ratio of donor to recipient DNA to be determined. Ideally, each electrophoretic peak (band)
should represent a single recipient or donor allele, so that determining %CHM would be trivial. One would sum the recipient DNA measurements and the donor DNA measurements and then calculate the recipient/donor ratio. This ideal is rarely achieved because routine CHM monitoring must deal with two problematic features of the STR platform. First, a single STR peak may contain DNA from the donors and recipient when the genomes of these individuals share the same allele, that is, have alleles with identical physico-chemical characteristics. In addition, owing to the similar genetic backgrounds of the DNA sources, for example, parent and child, shared peaks occur frequently in chimeric loci. 27, 32 Analytic problems arise because a shared peak will have only one measurement, and thus there is loss of information on its individual component alleles. 47 The second obstacle to quantitation with STRs is the phenomenon of allelic measurement error-typically 5-20%-which will naturally influence the accuracy of %CHM. 23, 32, 46 The process of calculating %CHM in DD cases is substantially more complex than it is for single-donor HSCTs. The presence of two donor DNA sources in the patient can produce chimeras with up to six alleles, instead of four. As will be shown shortly, sharing is common even among unrelated donors. At such loci, hundreds of possible configurations for allelic sharing are possible, many of which will result in the masking of critical recipient and donor measurements. Such extensive allelic sharing also interferes with assessing measurement error; 23, 46 therefore, even if %CHM could be estimated, its accuracy would be in doubt. Indeed, one could question whether it is ever possible to accurately assess CHM in such DD cases.
Despite these problems, values for CHM in DD HSCTs have been reported. 1, [4] [5] [6] [7] [8] [9] These results are difficult to interpret because insufficient details are provided in any study regarding the ad hoc computational procedures followed, the accuracy of the results or whether the measurements were assessed for reliability. It is uncertain whether any previous study analyzed loci with shared alleles, despite their common occurrence in DD HSCTs. Even the formula that must have been used to calculate the donor/recipient ratio for three DNA sources is uniformly omitted, despite several mathematical options for its formulation. Moreover, the few works that cite previously described procedures, as a basis to analyze DD samples, refer only to single-donor CHM analysis. 5, 12 Such procedures are not comparable, and cannot simply be extrapolated to DD cases for the reasons we considered earlier. In short, previous studies have not provided us with procedural directives that could serve as a basis for standardized analysis and reporting of these complex chimeras. This is the first study to specifically focus on these problems. It provides guidelines for each step of the analysis as well as simple, validated arithmetic procedures to calculate %CHM that are suitable for routine applications.
The goals of this study focused on the investigation of three aspects of DD-CHM: description of chimera, calculation of %CHM and validation of the results' accuracy. The first goal was to describe the phenomenon of DD-CHM in numeric terms, that is, frame the problem more precisely as a springboard for a quantitative solution.
To accomplish this goal, we investigated the following issues: the frequency of allelic sharing in DD chimeric peaks, the effect of sharing on allelic measurements and the informativity of different configurations. As we found that important allelic measurements are usually masked by sharing, any procedure for approximating %CHM would have to rely on measurements for shared peaks. The knowledge gained on the configurations of informative loci enabled us to fulfill our second goal: developing an efficient, stepwise procedure for calculating %CHM using available peak measurements. However, the results of this procedure are only approximations of the actual %CHM in the sample. Consequently, the third goal was to test the accuracy and validate such approximations, a critical requirement for routine applications. For this phase, hypothetical loci with predetermined reference values for CHM were used. This strategy permitted comparing a known reference value with results obtained using the approximation method. As the accuracy of the approximations also depends on using reliable measurements, an approach to reliability assessment of individual DD loci has been developed.
In addition to these technical contributions, the stepwise design of the study has provided novel guidelines and criteria for the standardized, routine analysis of multidonor chimeric states.
Methods

Study material
In all, 112 STR-DNA samples were evaluated in this study, providing 40 examples of DD-CHM for analysis. A total of 24 hypothetical loci were also fabricated and analyzed, as detailed below.
STR-PCR
As described previously, 32 DNA was extracted from blood and/or BM samples, and processed for multiplex PCR using the ABI AmpflSTR SGM Plus kit (ABI, Foster City, CA, USA), which has 10 polymorphic STR-PCR marker loci. STR-PCR products were electrophoresed and their fluorescence was measured by the ABI 3100 Genetic Analyzer (sequencer). The fluorescence intensity is an estimate of the quantity of amplicand in each electrophoretic peak (band), but owing to the absence of an internal calibration signal, the measurements do not correspond to absolute values of DNA.
Chimerism computation
Single-donor CHM (%CHM) was estimated from the peak area STR measurements [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] 48 based on the standard formula below.
Where R is recipient, D is donor; the shorter allele from any source will be, for example, Da1. The formula for DD-CHM is presented in the Results section.
Evaluation of frequency of allelic sharing A total of 24 STR loci based on eight STR markers were examined. An additional set of seven loci in a patient with two matched unrelated donors was examined. For each case, the number of peaks and the number of shared alleles in the locus were counted.
Hypothetical DD-CHM for validation experiments
To systematically vary allelic measurements and their error levels (Figure 1, D) so that the effects on %CHM could be documented, 12 hypothetical chimeric loci were constructed from entirely hypothetical allelic measurements based on typical error measurement levels between sister alleles (5-20%).
23,32
STR-loci for validation analysis Six DD chimeric STR loci, which are technically indistinguishable from mixed DNA clinical cases, were each fabricated from sets of three unrelated, normal DNA samples; these DNAs would correspond to D1, D2 and R in clinical material. Thus, each DD-CHM locus will have six alleles, but because of the high frequency of some of these alleles in our population, the alleles were often shared between DNA sources, that is, have the same STR repeat structure and size (bp). However, in this case, the STR measurement for each allele in each sample was known, allowing the calculation of a reference value for %CHM in the chimera. How these chimeras are used for validation is explained in the Results. The components of each chimera were culled from seven possible markers in the 5-FAM and JOE systems.
Performance of shared alleles A comparison of the measurement for a shared allele to its non-shared sister allele was carried out in seven serial samples from a patient who underwent a single-donor HSCT. The use of this material is explained in the appropriate section in the Results. Another patient with two sequential HSCTs from different donors was compared.
Statistics
For the results of the analysis in several sections, the mean, s.d. and Student's t-test were computed.
Results
For the sake of conceptual and experimental clarity, this investigation focused on cases in which all three DNA sources comprising a DD-CHM were heterozygous, that is, the chimera consists of three pairs of sister alleles, one pair from each source, as in the Figures. Homozygous alleles do occur, and their implications will be noted. In addition, our illustrations and simulations will be restricted to mixed donor CHM. The additional issues relevant to evaluating 0 or 100% have been dealt with previously.
23,46
Computing chimeric level in DD-CHM By way of an introduction to the analyses, this initial section describes a newly modified formula for %DD-CHM. STR peak measurements-area or heightare used to compute the % donor CHM ratio for each STR locus individually, as illustrated in Figure 1 . The computation requires summing all donor (D) allelic measurements, and dividing that sum by the sum of both donor and recipient (R) measurements (total DNA) in the same locus.
On the basis of this definition, we developed a general formula suitable for analyzing DD-CHM. It is analogous to that typically used for single-donor CHM (see Methods), [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] 48 but modified for six alleles as follows:
D1a1 refers to donor 1, allele a1; its sister allele is D1a2. To identify the correct source for each allele in the chimera, we compare the molecular size (bp) of chimeric peaks with the sizes of peaks in each of the source DNAs, as illustrated in Figure 2 .
It is important to note that this formula is completely accurate only when the measurements for each peak are accurate. 46 Measurement inaccuracies (error) are manifest by an inequality between sister alleles from the same individual ( Figure 1, D) , for example, D1a2 is smaller than D1a1; we assume here that the sensitivity of the assay is in the normal range. 46 This difference (D) is referred to henceforth as measurement error. Normally, this error ranges from 5 to 20%. For example, the measurement errors for the three pairs of sister alleles in Figure 1 are: D1, 21%; R, 8% and D2, 7%. . 46 We can identify the origin of each peak in a chimera by comparing the chimera to the electrophoretic displays for R, D1 and D2 as in Figures 3 and 4. The peak area measurement (center box) is made during electrophoresis, and estimates the quantity of DNA in one STR peak. Each locus must be individually analyzed because the platform lacks an internal calibration standard.
Frequency and configurations for shared alleles in DD-CHM In 24 haploidentical DD-chimeric loci, a single locus showed between two to five peaks, in which four to six alleles were shared, including homozygous alleles. Typically, a shared peak consisted of two to three alleles from different DNAs (R1, D1 and D2). Loci from an HSCT with double matched unrelated donors (n ¼ 7) gave similar results.
These findings provided a basis to define criteria for informative DD-CHM loci, as described in the following section.
Suitable locus configurations to calculate chimeric status
The goal here was to identify allelic configurations that would allow us to compute %DD-CHM indirectly when some of the critical R or D alleles were shared.
A total of 12 hypothetical DD-CHM loci were assessed with different configurations for shared and non-shared alleles. We found that a locus would be useful (informative) for analysis if it showed at least one of the following features:
one non-shared R allele (Table 1 , Figure 1 ), or a non-shared R homozygous peak ( Figure 2 ).
In short, loci with these features will be useful for approximating the sums of D and R measurements, which are needed for computing %CHM. The application of these guidelines is illustrated in 10 samples, some of which appear in the figures as well ( Table 1 ). The practical implications of these findings are applied in the following section.
Calculation of %CHM from available peak measurement in a DD locus On the basis of the foregoing observations, locus configurations usable for calculation generally fall into only two basic categories that depend on whether R alleles are shared or non-shared. Thus, two simple arithmetic procedures, or paths (Figures 4a and b) , can be used to calculate %CHM in most informative loci.
The goal of each arithmetic pathway in Figure 4 is to approximate the sums of R and D measurements by using the actual available STR peak measurements at a locus. The general strategy is as follows: (1) use or derive a Simultaneous Double -Donor HSCT Computing % Donor CHM: . Note that this locus can also be used by summing all of the D peaks, and using that value in the formula for 3-DNAs given in the text (see Results). Reliability of measurements was tested for this locus and found to be 88%, so that percent chimerism (%CHM) will be accurate. Locus (c) is non-informative (N-INF) because R and D2 alleles are all shared, but loci (d) and (e) are informative. Although measurements for locus (d) can be used directly, locus (e) requires using an approximation method for R alleles.
measurement for one R allele and one allele each from D1 and D2; (2) double the R allele, and (3) sum the D1 and D2 alleles, and double the sum.
In practice, only two or three simple steps are required to obtain the needed sums, as not all peak measurements are used. For instance, shared peaks frequently occur that contain a D1 and D2 allele, as in Figures 3a and 4b . In that case, the peak measurement only needs to be doubled to obtain the sum of D (Figure 4b ).
An uncommon variation of the locus in 4a shows a homozygous R allele that is shared in a single peak with two D alleles. The stepwise process of approximating %CHM is similar to that of Figure 4a , but one step simpler, and is shown in Figure 2 . Figure 3a also illustrates another case with a homozygous R allele that simplifies computation. This particular example could be solved in two ways. One way is the method shown in Figure 3b , which approximates the sum of D by doubling peak 1. Alternatively, the sum of D could have been determined by adding together the measurements for peaks 1, 3 and 4, and then the actual measurements can be directly applied to the formula (above) for %CHM.
The general accuracy of this approach is supported by the analyses in the validation section below. Importantly, none of these procedures is more complex than the process of actually computing %CHM from the formula (above). Computing %CHM Using Approximated Allelic Measurements
Figure 4 Computing percent chimerism (%CHM) using approximated allelic measurements. Two series of arithmetic steps are shown. Path (a) is used when all R alleles are shared; path (b) is used when a non-shared R allele is present in the locus. Figure 5 shows a hypothetical case using path (b).
Quantitating
Effects of sharing on allelic measurements
To simplify this analysis, loci from single-donor CHM samples were used that showed one shared peak (D1 þ R1) and two non-shared peaks (D2 þ R2). The question was whether the single measurement for the shared peak had the same value as the sum of its component alleles.
Although this question cannot be answered directly, it can be investigated indirectly by comparing the measurement of the shared allele with the sum of the two nonshared D and R alleles at these loci. For many cases, these values are nearly equal. For instance, in one typical chimeric STR locus, we found that the measurement for a shared peak was 24 137 U, whereas the sum of the two non-shared peaks was 23 967 U. These values were 99% equivalent, and the measurements were reliable according to previously detailed criteria. 23, 46, 47 A more systematic evaluation was carried out on a single locus over seven serial samples from one patient (Table 2) . In all samples, the magnitude of the shared peak was comparable to the sum of the two non-shared peaks (alleles), that is, the magnitudes were not statistically different (t-test, P ¼ 0.5).
These data suggest that a measurement for a shared peak can be quantitatively comparable to the sum of its shared alleles. The observations also provide one level of validation for using non-shared alleles to approximate allelic measurements in a shared peak, as proposed above (Figure 4) . The possible impact of allelic sharing on the proportionality between shared alleles is considered in the next section.
Validation: accuracy of %DD-CHM using approximated measurements Approximations of %CHM, as proposed above in Figure 4 , rely on peak measurements that represent only a few of the alleles in a chimera. Thus, some allelic measurements will be overestimated, some underestimated. Do such discrepancies influence the accuracy of the estimation? That is a key question that was addressed in this section of the study. The accuracy of approximations of %CHM was assessed by comparing the approximated (derived) results with a known reference value in loci with hypothetical measurements.
We refer to these analyses as numerical 'experiments.' Such experiments are necessary because they provide the only direct means for examining the effects on %CHM when allelic measurements, and error, are systematically varied. How such an experiment is performed and the results are considered below.
Using hypothetical chimeric loci. As the problem of accuracy originates with measurement error, and the error in a shared allele is unknowable (masked), we reverse the analytic process by asking the question: 'If we suppose that measurement error is such and such, then what will be the effect on %CHM approximations?' The actual experimental design is as follows:
Formulate hypothetical DD chimeric loci by assigning a measurement for each allele; measurement error is at 0% and sister alleles from each source have the same value. Incorporate measurement error by reducing the measurement for one allele in each pair of sister alleles from a single source (Figure 1, D) to produce an error of 5 or 20% (Table 3) . In Figure 5 , the error is 5%. Compute the reference %CHM from these six hypothetical allelic measurements using the formula (above). This is a precise value for the locus. In Figure 5 , the reference value is 72%. Compute the approximated %CHM from the same hypothetical locus. However, now 'we suppose' that the locus is an unknown sample, where we can only use the four peak measurements according to the schemes in Figure 4 . Consequently, this step is analogous to analyzing an actual clinical sample. In Figure 5 , the approximated value is 73%. Figure 5 Hypothetical double-donor chimerism with shared alleles and 5% measurement error. This is one of the cases analyzed for Table 3 . It is constructed from three hypothetical DNA samples (inset, left). In computing the reference percent chimerism (%CHM), all six allelic measurements in the simulation are applied to the formula (v. text). By contrast, approximated %CHM is the value obtained for this locus using procedure 4b (Figure 4 ) on just the peak measurements. The measurement for a shared peak used in the approximation is the sum of its components, as indicated by the values below the line. In this way, four numerical experiments were performed on the basis of the two locus configurations depicted in Figures 4a, b and 5 . To simplify comparison of results between cases, the same set of peak measurements was used; only the allelic composition of each peak changes between experiments. The latter point can be appreciated by comparing the locus in Figure 4a with that in Figure 4b , where, for example, Peak 1 is D1a1 in Figure 4a but Ra1 in Figure 4b ; in both cases, that peak measured 95 when measurement error was 5%, or 80 when error was 20%.
These peak measurements then provided reference values for %CHM of either 44 (Figure 4a ) or 72% (Figure 4b ). We analyzed 18 hypothetical chimeric loci that parallel real chimeric loci. For each locus, the approximated and reference values for %CHM were compared. It is worth emphasizing that this approach to validation is not an alternative for calculating %CHM on real samples, but only represents a useful experimental tool. The results of the experiments are summarized in Table 3 , parts A-D. The features of each of these experiments are as follows: Experiment 3A-the chimera's three pairs of alleles have the same measurement error (5 or 20%); Ra1 is shared (Figures 4a for 5%) . Experiment 3B-same, but Ra1 is non-shared (Figure 4b and 5) . Experiment 3C-the chimera's measurement error is varied only for D1 alleles to assess overestimating and underestimating allelic measurements on %CHM. (Compare Figure 5 , where using Peak 1 underestimates the sum of R). Experiment 3D-the chimera's error levels are unequal between pairs of sister alleles; Ra1 is shared. Table 3 shows that for all scenarios and examples, the values for approximated %CHM are within þ /À 5% of the reference value, which is an acceptable level of variability for loci in a given sample.
23,34
Using real STR measurements from random normal DNAs. Six DD chimeric STR loci, which are technically indistinguishable from mixed DNA clinical cases, were each fabricated from sets of three unrelated normal DNA samples; these DNAs would correspond with D1, D2 and R in clinical material. Thus, each DD-CHM locus has six alleles; but the alleles were often shared between DNA sources, that is, had the same STR repeat structure and size (bp). The allelic sharing reflected the high frequency of some alleles in our population. The features of each locus are summarized in Table 4 .
The allelic measurements were used in two ways: First, to approximate values for a shared sister allele and, second, to compute the reference value of %DD-CHM in six hypothetical chimeric loci from unrelated donors (see Methods). In contrast to the first set of experiments, the loci studied here tend to minimize sharing. In addition, the random number of peaks in a locus (three to five) and their ordering is random. Consequently, some peaks shared the sister allele with the error (Figure 1) , whereas others shared the allele without the error. The quantitative implication of this situation is that in some cases the shared allele was either over-or underestimated, similar to Table 3 Chimerism results using approximated measurements in hypothetical double-donor loci Abbreviations: Approx ¼ approximation procedure for %CHM based on measurements from shared peaks; CHM ¼ procedure for calculation %CHM. a Absolute (non-signed) magnitudes are used for the calculation as in Figure 3 , although for the sake of illustration and standardization the error is expressed in the table and text as percent. b Measurement error for one of two sister alleles from a single source in a pair of sister alleles from the same DNA source (Figure 1, D) . Figure 4 , so that D1a2 is the basis for approximating D1a1. When D1a2 has a 20% error, then it will underestimate D1a1, and vice versa.
the data in Table 3c . Nonetheless, it was observed ( Table 4) that the mean reference %CHM value for the six loci was 75%, s.d. ± 14% vs the mean of the approximated %CHM of 74%, ± 15%; the difference is not statistically significant (t-test, P ¼ 0.957). We also found that a shared allele could be reasonably approximated as the mean error of approximation was 8%, s.d. ± 6. Moreover, even when the approximated value of an allele is as much as 17% different from the reference value, the effect on %CHM is negligible, as shown in Table 4 .
Summary. Outcomes for all validation experiments showed several points. First, the proposed arithmetic approach for approximating %CHM (Figure 4 ) produced accurate results in all loci examined here. Second, the procedures in Figure 4 may overestimate and underestimate some alleles, but the net effect does not alter the accuracy of %CHM. Third, these findings are applicable over the typical range of allelic measurement errors found in real samples, that is, 5-20%. Fourth, the outcomes support the earlier conclusion that allelic sharing per se does not result in measurement error beyond the normal range typical of the STR assay.
Technical caveats. These results and conclusions presuppose that the STR assay has generated reliable measurements for a locus, with error levels below 20%, as generally required for accurate CHM values. 23, 46 Our tentative impression in this study is that loci will be technically satisfactory when the heights of the largest peaks are greater than 1000 RFU (relative fluorescence units), and four or five peaks are present.
In addition, measurement reliability can be systematically evaluated, as detailed previously. 23, 46, 47 In brief, one tests the measurement reliability at a locus by determining the ratio of measurements for the shorter alleles to those for the longer alleles. It should be emphasized that this is not an alternative to the formula for %CHM, but we are computing an entirely different parameter. The reliability computation was performed for the data in Figure 3b with a result of 88%. Loci with reliability over 80% generally produce highly accurate estimates of CHM. 23, 46, 47 Multiplex users have the advantage of comparing outcomes from different loci in the same sample; this has been shown to be a highly effective approach to assessing measurement reliability. 23, 47 A basic framework for routine monitoring of DD-CHM On the basis of the main findings of this investigation, we propose a framework for the routine analysis of %DD-CHM from STR loci with shared alleles. The major steps in that analysis would be as follows:
1. Select an informative locus: a non-shared R allele or non-shared D1 and D2 alleles. 2. Assess reliability of measurements for the locus. 
Discussion
Multi-donor HSCTs are a promising strategy to expedite engraftment and improve the outcome of transplantation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] However, the complex chimeric states associated with these transplants engender novel quantitative problems for the monitoring laboratory. The most challenging issue in analyzing multi-donor chimeras is the almost universal occurrence of shared alleles, that is, STR peaks (bands) with identical alleles from more than one DNA source. When the shared peak encompasses multiple R and D alleles, novel computational strategies are required to calculate %CHM. As can be seen from this study, the quantitative paradigm used for single-donor CHM 29, 34, 48 is not applicable here. The criterion for an 'informative' DD locus is different; validation of results and identifying measurement error is more complex, and even the formula for %CHM needs modification. Yet, no previous report of DD HSCTs has considered these issues or detailed the practical, specific procedures actually used for performing CHM analysis on these chimera.
1,4-9 Consequently, it seemed timely and important to rectify that omission here.
As the first study to systematically examine these problems, it makes novel contributions on several issues. Most importantly, this study provides a simple arithmetic procedure for approximating %CHM from loci with shared alleles, proves its accuracy and defines criteria for Table 4 Accuracy of approximated allelic measurements and the resultant %chimerism using real STR reference measurements in double-donor chimeric loci The difference between the measured reference value for an allele (Meas.) and the approximated (Approx) value for the same allele. c The approximated %CHM is the value obtained for this locus using procedures discussed in the text and in Figure 4 for peak measurements.
selecting loci to which it can be applied. It should be noted that as the approximation procedure relies on using peak measurements-whether shared or non-shared-it is directly applicable to real clinical samples that suffer the same limitation. Moreover, this approach is universally applicable to any type of multi-donor chimeric sample, regardless of the particular clinical context responsible for its creation.
As the approach focused on individual loci, it is relevant to both singleplex and multiplex platforms. Admittedly, the extent of sharing noted here for different types of DD HSCTs, may partially reflect the choice of STR markers. Our system is a standard commercial kit, optimized for forensic analysis, 23, 32 and consequently, it is possible that other marker systems 49 may generate fewer shared alleles. The origin of the donor DNA will also influence the frequency of sharing. For example, our tentative impression is that haploidentical dual-donor HSCTs will require using an approximation procedure more frequently than will unrelated donor double-unit umbilical cord blood HSCTs (unreported findings). Nonetheless, the genetic commonality among donors and recipients in DD-CHM would lead us to expect that the problems highlighted here will be regularly encountered and will need to be resolved. We have proposed one solution.
One obvious concern in relying on such an approach is that the results are only approximations of %CHM, with unknown levels of measurement error. Consequently, it was critical to prove, that is validate, the accuracy of the approach. Although it is obvious that inaccurate results can confound the assessment of engraftment status, relapse and so on, it should also be appreciated that inaccurate CHM values have little more than semi-quantitative implications of high, medium and low. 32, 47 The validity of these arithmetic procedures was proven by using hypothetical DD chimeric loci with known %CHM values. This allowed us to systematically compare the approximated %CHM with a reference value; the latter is based on the known measurements for each allele. The results of these analyses confirm that the accuracy of the approximated %CHM is within the acceptable limits of ± 5%. 23 Using hypothetical chimera offered several advantages over physically fabricating actual artificial chimeras, including greater precision. 32 In addition, this type of validation process would be impossible to undertake in clinical material, where the results are unknown by definition. Only in these hypothetical chimeric loci is it possible to precisely compare the approximated results with a known reference value.
Outcomes from this study showed a number of points worth highlighting. In terms of routine monitoring, it was important to find that although most loci could be used for computing %CHM, some were 'non-informative.' The characteristics for informative loci were easily defined, and highlighted the strategic importance of using and/or approximating the measurement for the R alleles. Of course, calculating %CHM requires information on D alleles as well, but the observation on the R alleles was particularly useful because it allowed simplifying the arithmetic calculations for %DD-CHM. In most instances, only two to three steps are required involving addition, subtraction and/or doubling, depending on whether R is shared or non-shared.
One finding was unexpected. We observed in the course of the validation experiments that DD chimera might show large measurement errors in multiple alleles without a significant effect on the accuracy of %CHM; the results remain within the normal range of ±5% variability. The phenomenon is probably due to a balancing effect originating in the relatively large number of alleles present in a DD-CHM and the consequently large numerical values for the sum of D and/or sum of R used in the formula for %CHM. A similar phenomenon has been reported for single donor cases as well. 46 Nonetheless, it would seem prudent to assess measurement reliability for any locus being analyzed. It could be carried out in a minimal way, as suggested above, or more elaborately as detailed previously. 23, 46 In aggregate, the current investigation provides a framework for standardized, routine monitoring of DD-CHM based on the STR/VNTR assay. Standardizing CHM analysis for these cases would facilitate critical assessment of a promising advance in HSCT.
